1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Progression: new trials by email Literature Review of Progression trials Research Report on Progression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Omitting CTV for Primary Tumor in LS-SCLC Radiation Therapy, Etoposide + carboplatin; Etoposide + cisplatin, Creating CTV for primary tumor - SCLC, Limited Stage, Radiation Exposure | Phase 3 | Recruiting | Sun Yat-sen University | 852 | 2025-06-03 | 2025-06-06 |
Disease Progression (1) · Radiation Injuries (1)
Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Wounds and Injuries (1)
Carboplatin (1) · Cisplatin (1) · Etoposide (1) · Radiotherapy (1)
China (1)